Pachner A - Search Results

Year	Number of Results
1956	1
1976	1
1979	1
1980	1
1982	1
1983	2
1984	2
1985	4
1986	5
1987	5
1988	1
1989	6
1990	4
1991	4
1992	3
1993	2
1994	4
1995	4
1996	1
1997	2
1998	3
1999	3
2000	1
2001	5
2002	2
2003	6
2004	5
2005	5
2006	2
2007	10
2008	2
2009	4
2010	3
2011	4
2012	1
2014	1
2015	4
2016	3
2017	3
2018	5
2019	4
2020	3
2021	3
2022	4
2023	2
2024	1

1

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.

Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators. Kappos L, et al. Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23. Lancet. 2018. PMID: 29576505 Clinical Trial.

2

Lyme disease.

Pachner AR. Pachner AR. Trends Neurosci. 1989 May;12(5):177-81. doi: 10.1016/0166-2236(89)90065-9. Trends Neurosci. 1989. PMID: 2472690 Review.

3

SeXX Matters in Multiple Sclerosis.

Gilli F, DiSano KD, Pachner AR. Gilli F, et al. Among authors: pachner ar. Front Neurol. 2020 Jul 3;11:616. doi: 10.3389/fneur.2020.00616. eCollection 2020. Front Neurol. 2020. PMID: 32719651 Free PMC article. Review.

4

Neutralizing antibodies to biological therapies: A "touch of gray" vs a "black and white" story.

Freedman MS, Pachner AR. Freedman MS, et al. Among authors: pachner ar. Neurology. 2007 Oct 2;69(14):1386-7. doi: 10.1212/01.wnl.0000282011.92098.68. Neurology. 2007. PMID: 17909150 No abstract available.

5

The CXCL13 Index as a Predictive Biomarker for Activity in Clinically Isolated Syndrome.

Pike SC, Gilli F, Pachner AR. Pike SC, et al. Among authors: pachner ar. Int J Mol Sci. 2023 Jul 4;24(13):11050. doi: 10.3390/ijms241311050. Int J Mol Sci. 2023. PMID: 37446228 Free PMC article.

6

Clinical utility of a molecular signature in inflammatory demyelinating disease.

Pachner AR, DiSano K, Royce DB, Gilli F. Pachner AR, et al. Neurol Neuroimmunol Neuroinflamm. 2018 Nov 9;6(1):e520. doi: 10.1212/NXI.0000000000000520. eCollection 2019 Jan. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 30568998 Free PMC article.

7

Experimental models of multiple sclerosis.

Pachner AR. Pachner AR. Curr Opin Neurol. 2011 Jun;24(3):291-9. doi: 10.1097/WCO.0b013e328346c226. Curr Opin Neurol. 2011. PMID: 21519255 Review.

8

High throughput method for detecting murine brain atrophy using a clinical 3T MRI.

Linzey M, DiSano K, Welsh N, Ford JC, Gilli F, Wishart H, Pachner A. Linzey M, et al. Among authors: pachner a. BMC Med Imaging. 2023 Nov 13;23(1):183. doi: 10.1186/s12880-023-01124-0. BMC Med Imaging. 2023. PMID: 37957588 Free PMC article.

9

The Neuroimmunology of Multiple Sclerosis: Fictions and Facts.

Pachner AR. Pachner AR. Front Neurol. 2022 Feb 7;12:796378. doi: 10.3389/fneur.2021.796378. eCollection 2021. Front Neurol. 2022. PMID: 35197914 Free PMC article. Review.

10

CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker of Disease Activity.

Welsh N, Disano K, Linzey M, Pike SC, Smith AD 3rd, Pachner AR, Gilli F. Welsh N, et al. Among authors: pachner ar. Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200200. doi: 10.1212/NXI.0000000000200200. Epub 2024 Feb 12. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38346270 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year